Diadem Partners with Dementias Platform UK to Advance Diagnosis and Treatment of Alzheimer’s Disease

Diadem Partners with Dementias Platform UK to Advance Diagnosis and Treatment of Alzheimer's Disease/Read Magazine

Diadem SpA, a company developing AlzoSure Predict, the first blood-based test for the early prediction of progression to Alzheimer’s disease (AD), announced that is has joined Dementias Platform UK (DPUK) as a corporate partner. Also Read: MEDICALGORITHMICS Secured FDA Approval for Qpatch Wearable DPUK is a public private partnership funded by the UK Medical Research… Continue reading Diadem Partners with Dementias Platform UK to Advance Diagnosis and Treatment of Alzheimer’s Disease

Shimadzu Medical Systems announces Release of New Angiography System at the SIR 2022

Shimadzu Medical Systems announces Release of New Angiography System at the SIR 2022/Read Magazine

Shimadzu Corporation will commence worldwide sales of its flagship newest version of its Trinias™ angiography system. Shimadzu Medical Systems USA will introduce our innovative new technology solutions in angiography at the SIR 2022 conference, starting on Sunday, June 12, 2022. Also Read: MEDICALGORITHMICS Secured FDA Approval for Qpatch Wearable The new Trinias system uses AI… Continue reading Shimadzu Medical Systems announces Release of New Angiography System at the SIR 2022

Zavation Medical Products, LLC, receives FDA 510K Clearance for eZspand Lateral Cage as an addition to its eZspand Interbody System

Zavation Medical Products_ LLC_ receives FDA 510K Clearance for eZspand™ Lateral Cage as an addition to its eZspand™ Interbody System./Read Magazine

Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced the FDA 510K Clearance of eZspand™ Lateral, an expandable lumbar interbody fusion device. Also Read: MEDICALGORITHMICS Secured FDA Approval for Qpatch Wearable The eZspand™ Lateral, part of the… Continue reading Zavation Medical Products, LLC, receives FDA 510K Clearance for eZspand Lateral Cage as an addition to its eZspand Interbody System

Resolution Medical Acquires LifeTec Group

Resolution Medical Acquires LifeTec Group™/Read Magazine

Resolution Medical, a portfolio company of Arcline Investment Management and a premier vertically integrated medical device contract development and manufacturing organization (CDMO), announced that it has acquired LifeTec Group™ (“LifeTec”). Based in Eindhoven, the Netherlands, LifeTec is a leading global pre-clinical contract research organization (CRO) focused on the investigation and demonstration of medical device innovations… Continue reading Resolution Medical Acquires LifeTec Group

MEDICALGORITHMICS Secured FDA Approval for Qpatch Wearable

MEDICALGORITHMICS secured FDA approval for Qpatch wearable/Read Magazine

Qpatch is a state-of-the-art wearable device for measuring individual ECG signal to obtain accurate cardiac arrhythmia diagnosis across many days. It allows ECG monitoring sessions, lasting up to 15 days, for a single patient. Also Read: KP Performance Antennas Launches Wide-Band, Log Periodic, Directional Antennas “Securing the FDA approval for Qpatch is a major milestone… Continue reading MEDICALGORITHMICS Secured FDA Approval for Qpatch Wearable

LumiraDx Achieves CE Mark for COVID-19 Antigen Test on Amira, its New Low-Cost Testing System

LumiraDx Achieves CE Mark for COVID-19 Antigen Test on Amira_ its New Low-Cost Testing System/Read Magazine

LumiraDx Limited, a next-generation point of care diagnostics company, announced that it has achieved CE Mark for the Amira System, its new testing system that provides low-cost, highly sensitive COVID-19 testing. The Amira Analyzer reads the included Amira SARS-CoV-2 Ag test strips and returns a result in just 15 minutes. The Amira Analyzer condenses technology… Continue reading LumiraDx Achieves CE Mark for COVID-19 Antigen Test on Amira, its New Low-Cost Testing System

Evidence Partners and Akra Team Form Partnership to Help Medical Device Companies Accelerate the Completion of EU MDR and IVDR Submissions

Evidence Partners and Akra Team Form Partnership to Help Medical Device Companies Accelerate the Completion of EU MDR and IVDR Submissions/Read Magazine

Evidence Partners Inc., a market leader in AI-enabled literature review automation software and creator of DistillerSR, announced a collaboration with Akra Team, a German-based strategic regulatory consultancy, to deliver end-to-end consulting services that make it easier and faster for medical device companies to complete EU MDR and IVDR notified body submissions. The partnership brings together… Continue reading Evidence Partners and Akra Team Form Partnership to Help Medical Device Companies Accelerate the Completion of EU MDR and IVDR Submissions

KP Performance Antennas Launches Wide-Band, Log Periodic, Directional Antennas

KP Performance Antennas Launches Wide-Band_ Log Periodic_ Directional Antennas/Read Magazine

KP Performance Antennas, an Infinite Electronics brand and a manufacturer of wireless network antennas, has just introduced a new series of wide-band, log periodic, directional antennas covering 790 MHz to 6 GHz to address myriad wireless networking applications. Also Read: TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) KP’s new series of wide-band, log… Continue reading KP Performance Antennas Launches Wide-Band, Log Periodic, Directional Antennas

One Drop Study Signals Significant Growing Interest in Continuous Glucose Monitors (CGMs) Among People with Type 2 Diabetes (T2D)

One Drop Study Signals Significant Growing Interest in Continuous Glucose Monitors (CGMs) Among People with Type 2 Diabetes (T2D)/Read Magazine

One Drop, a leader in precision health solutions for people living with diabetes and other chronic conditions, presented new research at the 82nd Scientific Sessions of the American Diabetes Association on attitudes and adoption of continuous glucose monitors (CGM) among people with type 2 diabetes (T2D). Also Read: RxBIO Launches Neogen Plasma Skin Rejuvenation in… Continue reading One Drop Study Signals Significant Growing Interest in Continuous Glucose Monitors (CGMs) Among People with Type 2 Diabetes (T2D)

Imaging Endpoints (IE) and ImaginAb Inc Expand Partnership – IE to Supply Clinical Doses of CD8 Imaging Agent to BioPharma Companies

Imaging Endpoints (IE) and ImaginAb Inc Expand Partnership - IE to Supply Clinical Doses of CD8 Imaging Agent to BioPharma Companies/Read Magazine

Imaging Endpoints (IE) and ImaginAb announced that after collaborating for nearly a decade they have entered into a license agreement for IE to directly offer clinical doses of ImaginAb’s CD8 investigational ImmunoPET (zirconium Zr 89 crefmirlimab berdoxam) imaging agent for clinical trials as part of Imaging Endpoints’ industry-leading imaging CRO services. Also Read: RxBIO Launches… Continue reading Imaging Endpoints (IE) and ImaginAb Inc Expand Partnership – IE to Supply Clinical Doses of CD8 Imaging Agent to BioPharma Companies